Pharma Reaserch (Korea) Performance

214450 Stock  KRW 247,000  3,500  1.44%   
Pharma Reaserch has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of -0.24, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pharma Reaserch are expected to decrease at a much lower rate. During the bear market, Pharma Reaserch is likely to outperform the market. Pharma Reaserch Prod right now holds a risk of 3.68%. Please check Pharma Reaserch Prod semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if Pharma Reaserch Prod will be following its historical price patterns.

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Reaserch Prod are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Pharma Reaserch may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
  

Pharma Reaserch Relative Risk vs. Return Landscape

If you would invest  23,300,000  in Pharma Reaserch Prod on October 27, 2024 and sell it today you would earn a total of  1,200,000  from holding Pharma Reaserch Prod or generate 5.15% return on investment over 90 days. Pharma Reaserch Prod is generating 0.1519% of daily returns and assumes 3.6804% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than Pharma, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Pharma Reaserch is expected to generate 4.28 times more return on investment than the market. However, the company is 4.28 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Pharma Reaserch Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharma Reaserch's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharma Reaserch Prod, and traders can use it to determine the average amount a Pharma Reaserch's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0413

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns214450
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.68
  actual daily
32
68% of assets are more volatile

Expected Return

 0.15
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
3
97% of assets perform better
Based on monthly moving average Pharma Reaserch is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharma Reaserch by adding it to a well-diversified portfolio.

About Pharma Reaserch Performance

By analyzing Pharma Reaserch's fundamental ratios, stakeholders can gain valuable insights into Pharma Reaserch's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharma Reaserch has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharma Reaserch has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about Pharma Reaserch Prod performance evaluation

Checking the ongoing alerts about Pharma Reaserch for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharma Reaserch Prod help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pharma Reaserch Prod had very high historical volatility over the last 90 days
Evaluating Pharma Reaserch's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Pharma Reaserch's stock performance include:
  • Analyzing Pharma Reaserch's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharma Reaserch's stock is overvalued or undervalued compared to its peers.
  • Examining Pharma Reaserch's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Pharma Reaserch's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharma Reaserch's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Pharma Reaserch's stock. These opinions can provide insight into Pharma Reaserch's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Pharma Reaserch's stock performance is not an exact science, and many factors can impact Pharma Reaserch's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Pharma Stock analysis

When running Pharma Reaserch's price analysis, check to measure Pharma Reaserch's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Reaserch is operating at the current time. Most of Pharma Reaserch's value examination focuses on studying past and present price action to predict the probability of Pharma Reaserch's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Reaserch's price. Additionally, you may evaluate how the addition of Pharma Reaserch to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules